Advertisement admin, Author at Pharmaceutical Business review - Page 389 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by Andrew 

Mallinckrodt receives US patent for Xartemis XR

Xartemis XR (formerly known as MNK-795) is an investigational extended-release oral formulation of oxycodone and acetaminophen that has been studied with twice daily dosing for the management of